Previous close | 4.2200 |
Open | 3.6000 |
Bid | 4.3400 x N/A |
Ask | 4.4400 x N/A |
Day's range | 3.6000 - 3.6000 |
52-week range | 2.5000 - 4.8400 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Discover how MaxCyte Inc (MXCT) achieved significant revenue increases and strategic advancements in the first quarter of 2024.
MaxCyte (MXCT) delivered earnings and revenue surprises of 35.71% and 46.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?